VivoSim Labs and Chemveda Life Sciences have formed a strategic collaboration to accelerate drug discovery by testing AI-designed drug compounds using VivoSim's 3D human liver and intestine tissue models. This partnership aims to quickly identify which AI-generated molecules are safe and effective, reducing the time and cost typically required for drug development. VivoSim's models have demonstrated high accuracy in predicting drug-induced liver injury, surpassing traditional animal testing methods. The collaboration will offer faster, human-relevant safety data to pharmaceutical clients starting Q4 2026, aligning with FDA encouragement to use non-animal testing methods.
VivoSim Labs and Chemveda Life Sciences' collaboration on AI-designed drug candidates comes as 75 of 150 Health-sector US stocks traded on Pluang rose today. For readers following this sector, here is Pluang's market snapshot as of Nov 03, 2026 20:11 WIB: Vertex Pharmaceuticals Incorporated (VRTX) traded at USD 565.98, up 2.32% with a typical hold time of 123 days and 75% buy order activity; Twist Bioscience Corp (TWST) was at USD 131.82, up 2.15% with a 27-day hold time and 82% buy orders; Brookdale Senior Living Inc. (BKD) fell 2.68% to USD 10.16, with a 19-day hold time.
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...
